Identification of seven novel cryptic exons embedded in the dystrophin gene and characterization of 14 cryptic dystrophin exons

Journal of Human Genetics

Volumn 52, Issue 7, 2007, Pages 607-617

  Zhang, Zhujun ^a   Habara, Yasuaki ^a   Nishiyama, Atsushi ^a   Oyazato, Yoshinobu ^a   Yagi, Mariko ^a   Takeshima, Yasuhiro ^a   Matsuo, Masafumi ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cryptic exon; Dystrophin; mRNA; Splicing

Indexed keywords

DYSTROPHIN; MESSENGER RNA;

ARTICLE; COMPARATIVE STUDY; DUCHENNE MUSCULAR DYSTROPHY; DYSTROPHINOPATHY; EXON; GENE AMPLIFICATION; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; GENE SILENCING; GENETIC ANALYSIS; GENETIC DISORDER; GENETIC PARAMETERS; HUMAN; INTRON; LYMPHOCYTE; MAJOR CLINICAL STUDY; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PROTEIN MOTIF; RNA ISOLATION; RNA SPLICING; STOP CODON;

ALTERNATIVE SPLICING; BASE SEQUENCE; CELLS, CULTURED; DYSTROPHIN; EXONS; HUMANS; INTRONS; MOLECULAR SEQUENCE DATA; MUSCULAR DYSTROPHY, DUCHENNE; RNA, MESSENGER;

EID: 34347366205     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10038-007-0163-0     Document Type: Article

References (61)

1. Adachi K, Takeshima Y, Wada H, Yagi M, Nakamura H, Matsuo M (2003) Heterogous dystrophin mRNAs produced by a novel splice acceptor site mutation in intermediate dystrophinopathy. Pediatr Res 53:125-131
2. Ahn AH, Kunkel LM (1993) The structural and functional diversity of dystrophin. Nat Genet 3:283-291
3. Baek D, Green P (2005) Sequence conservation, relative isoform frequencies, and nonsense-mediated decay in evolutionarily conserved alternative splicing. Proc Natl Acad Sci USA 102:12813-12818
4. Barbieri AM, Soriani N, Ferlini A, Michelato A, Ferrari M, Carrera P (1996) Seven novel additional small mutations and a new alternative splicing in the human dystrophin gene detected by heteroduplex analysis and restricted RT-PCR heteroduplex analysis of illegitimate transcripts. Eur J Hum Genet 4:183-187
5. Beggs AH, Koenig M, Boyce FM, Kunkel LM (1990) Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction. Hum Genet 86:45-48
6. Beroud C, Carrie A, Beldjord C, Deburgrave N, Llense S, Carelle N, Peccate C, Cuisset JM, Pandit F, Carre-Pigeon F, Mayer M, Bellance R, Recan D, Chelly J, Kaplan JC, Leturcq F (2004) Dystrophinopathy caused by mid-intronic substitutions activating cryptic exons in the DMD gene. Neuromuscul Disord 14:10-18
7. Boyce FM, Beggs AH, Feener C, Kunkel LM (1991) Dystrophin is transcribed in brain from a distant upstream promoter. Proc Natl Acad Sci USA 88:1276-1280
8. Burnette JM, Miyamoto-Sato E, Schaub MA, Conklin J, Lopez AJ (2005) Subdivision of large introns in Drosophila by recursive splicing at nonexonic elements. Genetics 170:661-674
9. Byers TJ, Lidov HG, Kunkel LM (1993) An alternative dystrophin transcript specific to peripheral nerve. Nat Genet 4:77-81
10. Carninci P, Kasukawa T, Katayama S, Gough J, Frith MC, Maeda N, Oyama R et al. (2005) The transcriptional landscape of the mammalian genome. Science 309:1559-1563
11. Chamberlain JS, Gibbs RA, Ranier JE, Nguyen PN, Caskey CT (1988) Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. Nucleic Acids Res 16:11141-11156
12. Chelly J, Gilgenkrantz H, Hugnot JP, Hamard G, Lambert M, Recan D, Akli S, Cometto M, Kahn A, Kaplan JC (1991) Illegitimate transcription. Application to the analysis of truncated transcripts of the dystrophin gene in nonmuscle cultured cells from Duchenne and Becker patients. J Clin Invest 88:1161-1166
13. Claverie JM (2005) Fewer genes, more noncoding RNA. Science 309:1529-1530
14. Den Dunnen JT, Grootscholten PM, Bakker E, Blonden LA, Ginjaar HB, Wapenaar MC, van Paassen HM, van Broeckhoven C, Pearson PL, van Ommen GJ (1989) Topography of the Duchenne muscular dystrophy (DMD) gene: FIGE and cDNA analysis of 194 cases reveals 115 deletions and 13 duplications. Am J Hum Genet 45:835-847
15. Dwi Pramono ZA, Takeshima Y, Surono A, Ishida T, Matsuo M (2000) A novel cryptic exon in intron 2 of the human dystrophin gene evolved from an intron by acquiring consensus sequences for splicing at different stages of anthropoid evolution. Biochem Biophys Res Commun 267:321-328
16. Eng L, Coutinho G, Nahas S, Yeo G, Tanouye R, Babaei M, Dork T, Burge C, Gatti RA (2004) Nonclassical splicing mutations in the coding and noncoding regions of the ATM Gene: maximum entropy estimates of splice junction strengths. Hum Mutat 23:67-76
17. Gangopadhyay SB, Sherratt TG, Heckmatt JZ, Dubowitz V, Miller G, Shokeir M, Ray PN, Strong PN, Worton RG (1992) Dystrophin in frameshift deletion patients with Becker muscular dystrophy. Am J Hum Genet 51:562-570
18. Gorecki DC, Monaco AP, Derry JMJ, Walker AP, Barnard EA, Barnard PJ (1992) Expression of four alternative dystrophin transcripts in brain regions regulated by different promoters. Hum Mol Genet 1:505-510
19. Hatton AR, Subramaniam V, Lopez AJ (1998) Generation of alternative Ultrabithorax isoforms and stepwise removal of a large intron by resplicing at exon-exon junctions. Mol Cell 2:787-796
20. Hillman RT, Green RE, Brenner SE (2004) An unappreciated role for RNA surveillance. Genome Biol 5:R8
21. Holder E, Maeda M, Bies RD (1996) Expression and regulation of the dystrophin purkinje promoter in human skeletal muscle, heart, and brain. Hum Genet 97:232-239
22. Ikezawa M, Minami N, Takahashi M, Goto Y, Miike T, Nonaka I (1998) Dystrophin gene analysis on 130 patients with Duchenne muscular dystrophy with a special reference to muscle mRNA analysis. Brain Dev 20:165-168
23. Ishibashi K, Takeshima Y, Yagi M, Nishiyama A, Matsuo M (2006) Novel cryptic exons identified in introns 2 and 3 of the human dystroiphin gene with duplication of exons 8-11. Kobe J Med Sci 52:61-75
24. Ishii S, Nakao S, Minamikawa-Tachino R, Desnick RJ, Fan JQ (2002) Alternative splicing in the alpha-galactosidase A gene: increased exon inclusion results in the Fabry cardiac phenotype. Am J Hum Genet 70:994-1002
25. Klamut HJ, Gangopadhyay SB, Worton RG, Ray PN (1990) Molecular and functional analysis of the muscle specific promoter region of the Duchenne muscular dystrophy gene. Mol Cell Biol 10:193-205
26. Koenig M, Hoffman EP, Bertelson CJ, Monaco AP, Feener C, Kunkel LM (1987) Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 50:509-517
27. Ladd AN, Cooper TA (2002) Finding signals that regulate alternative splicing in the post-genomic era. Genome Biol 3:8.1-8.16
28. Lareau LF, Green RE, Bhatnagar RS, Brenner SE (2004) The evolving roles of alternative splicing. Curr Opin Struct Biol 14:273-282
29. Lederfein D, Yaffe D, Nudel U (1993) A housekeeping type promoter, located in the 3′ region of the Duchenne muscular dystrophy gene, controls the expression of Dp71, a major product of the gene. Hum Mol Genet 2:1883-1888
30. Lev-Maor G, Sorek R, Shomron N, Ast G (2003) The birth of an alternatively spliced exon: 3′ splice-site selection in Alu exons. Science 300:1288-1291
31. Lidov HG, Selig S, Kunkel LM (1995) Dp140: a novel 140 kDa CNS transcript from the dystrophin locus. Hum Mol Genet 4:329-335
32. Malhotra SB, Hart KA, Klamut HJ, Thomas NST, Bodrug E, Burghes AHM, Borrow M, Harper PS, Thompson W, Ray PN (1988) Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy. Science 242:755-759
33. Maquat LE (2004) Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics. Nat Rev Mol Cell Biol 5:89-99
34. Matsuo M, Masumura T, Nakajima T, Kitoh Y, Takumi T, Nishio H, Koga J, Nakamura H (1990) A very small frame-shifting deletion within exon 19 of the Duchenne muscular dystrophy gene. Biochem Biophys Res Commun 170:963-967
35. Matsuo M, Masumura T, Nishio H, Nakajima T, Kitoh Y, Takumi T, Koga J, Nakamura H (1991) Exon skipping during splicing of dystrophin mRNA precursor due to an intraexon deletion in the dystrophin gene of Duchenne muscular dystrophy Kobe. J Clin Invest 87:2127-2131
36. McNaughton JC, Hughes G, Jones WA, Stockwell PA, Klamut HJ, Petersen GB (1997) The evolution of an intron: analysis of a long, deletion-prone intron in the human dystrophin gene. Genomics 40:294-304
37. Metherell LA, Akker SA, Munroe PB, Rose SJ, Caulfield M, Savage MO, Chew SL, Clark AJ (2001) Pseudoexon activation as a novel mechanism for disease resulting in atypical growth-hormone insensitivity. Am J Hum Genet 69:641-646
38. Nishio H, Takeshima Y, Narita N, Yanagawa H, Suzuki Y, Ishikawa Y, Minami R, Nakamura H, Matsuo M (1994) Identification of a novel first exon in the human dystrophin gene and of a new promoter located more than 500 kb upstream of the nearest known promoter. J Clin Invest 94:1037-1042
39. Pagani F, Buratti E, Stuani C, Bendix R, Dork T, Baralle FE (2002) A new type of mutation causes a splicing defect in ATM. Nature Genet 30:426-429
40. Pillers D-AM, Bulman DE, Welber RG, Sigesmund DA, Musarella MA, Powell BR, Murphey WH, Westall C, Panton C, Becker LE, Worton RG, Ray PN (1993) Dystrophin expression in the human retina is required for normal function as defined by electroretinography. Nature Genet 4:82-86
41. Pozzoli U, Sironi M (2005) Silencers regulate both constitutive and alternative splicing events in mammals. Cell Mol Life Sci 62:1579-1604
42. Reiss J, Rininsland F (1994) An explanation for the constitutive exon 9 cassette splicing of the DMD gene. Hum Mol Genet 3:295-298
43. Roberts RG, Barby TF, Manners E, Bobrow M, Bentley DR (1991) Direct detection of dystrophin gene rearrangements by analysis of dystrophin mRNA in peripheral blood lymphocytes. Am J Hum Genet 49:298-310
44. Roberts RG, Bentley DR, Bobrow M (1993) Infidelity in the structure of ectopic transcripts: a novel exon in lymphocyte dystrophin transcripts. Hum Mutat 2:293-299
45. Roca X, Sachidanandam R, Krainer AR (2003) Intrinsic differences between authentic and cryptic 5′ splice sites. Nucleic Acids Res 31:6321-6333
46. Senapathy P, Shapiro MB, Harris NL (1990) Splice junctions, branch point sites, and exons: sequence statistics, identification, and applications to genome project. Methods Enzymol 183:252-278
47. Shapiro MB, Senapathy P (1987) RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucleic Acids Res 15:7155-7174
48. Shiga N, Takeshima Y, Sakamoto H, Inoue K, Yokota Y, Yokoyama M, Matsuo M (1997) Disruption of the splicing enhancer sequence within exon 27 of the dystrophin gene by a nonsense mutation induces partial skipping of the exon and is responsible for Becker muscular dystrophy. J Clin Invest 100:2204-2210
49. Sironi M, Menozzi G, Riva L, Cagliani R, Comi GP, Bresolin N, Giorda R, Pozzoli U (2004) Silencer elements as possible inhibitors of pseudoexon splicing. Nucleic Acids Res 32:1783-1791
50. Sironi M, Pozzoli U, Cagliani R, Comi GP, Bardoni A, Bresolin N (2001) Analysis of splicing parameters in the dystrophin gene: relevance for physiological and pathogenetic splicing mechanisms. Hum Genet 109:73-84
51. Sorek R, Lev-Maor G, Reznik M, Dagan T, Belinky F, Graur D, Ast G (2004) Minimal conditions for exonization of intronic sequences: 5′ splice site formation in alu exons. Mol Cell 14:221-231
52. Suminaga R, Takeshima Y, Adachi K, Yagi M, Nakamura H, Matsuo M (2002) A novel cryptic exon in intron 3 of the dystrophin gene was incorporated into dystrophin mRNA with a single nucleotide deletion in exon 5. J Hum Genet 47:196-201
53. Sun H, Chasin LA (2000) Multiple splicing defects in an intronic false exon. Mol Cell Biol 20:6414-6425
54. Surono A, Takeshima Y, Wibawa T, Ikezawa M, Nonaka I, Matsuo M (1999) Circular dystrophin RNAs consisting of exons that were skipped by alternative splicing. Hum Mol Genet 8:493-500
55. Surono A, Takeshima Y, Wibawa T, Pramono ZA, Matsuo M (1997) Six novel transcripts that remove a huge intron ranging from 250 to 800 kb are produced by alternative splicing of the 5′ region of the dystrophin gene in human skeletal muscle. Biochem Biophys Res Commun 239:895-899
56. Thi Tran HT, Takeshima Y, Surono A, Yagi M, Wada H, Matsuo M (2005) A G-to-A transition at the fifth position of intron 32 of the dystrophin gene inactivates a splice donor site both in vivo and in vitro. Mol Genet Metab 85:213-219
57. Torelli S, Muntoni F (1996) Alternative splicing of dystrophin exon 4 in normal human muscle. Hum Genet 97:521-523
58. Tran VK, Zhang Z, Yagi M, Nishiyama A, Habara Y, Takeshima Y, Matsuo M (2005) A novel cryptic exon identified in the 3′ region of intron 2 of the human dystrophin gene. J Hum Genet 50:425-433
59. Tuffery-Giraud S, Saquet C, Chambert S, Claustres M (2003) Pseudoexon activation in the DMD gene as a novel mechanism for Becker muscular dystrophy. Hum Mutat 21:608-614
60. Yagi M, Takeshima Y, Wada H, Nakamura H, Matsuo M (2003) Two alternative exons can result from activation of the cryptic splice acceptor site deep within intron 2 of the dystrophin gene in a patient with as yet asymptomatic dystrophinopathy. Hum Genet 112:164-170
61. Yeo GW, Van Nostrand E, Holste D, Poggio T, Burge CB (2005) Identification and analysis of alternative splicing events conserved in human and mouse. Proc Natl Acad Sci USA 102:2850-2855